Is Kazia Therapeutics Ltd (KZIA) Stock at the Top of the Biotechnology Industry?

Friday, July 07, 2023 10:02 AM | InvestorsObserver Analysts

Mentioned in this article

Is Kazia Therapeutics Ltd (KZIA) Stock at the Top of the Biotechnology Industry?

A rating of 49 puts Kazia Therapeutics Ltd (KZIA) near the middle of the Biotechnology industry according to InvestorsObserver. Kazia Therapeutics Ltd's score of 49 means it scores higher than 49% of stocks in the industry. Kazia Therapeutics Ltd also received an overall rating of 46, putting it above 46% of all stocks. Biotechnology is ranked 35 out of the 148 industries.

KZIA has an Overall Score of 46. Find out what this means to you and get the rest of the rankings on KZIA!

See Full KZIA Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Kazia Therapeutics Ltd Stock Today?

Kazia Therapeutics Ltd (KZIA) stock is unchanged 0.04% while the S&P 500 is up 0.07% as of 9:55 AM on Friday, Jul 7. KZIA is flat $0.00 from the previous closing price of $1.07 on volume of 69,102 shares. Over the past year the S&P 500 has risen 13.12% while KZIA has fallen -73.84%. KZIA lost -$1.20 per share the over the last 12 months. Click Here to get the full Stock Report for Kazia Therapeutics Ltd stock.